These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25891112)

  • 21. Effects of cyclo (his-pro) plus zinc on glucose metabolism in genetically diabetic obese mice.
    Hwang IK; Go VL; Harris DM; Yip I; Kang KW; Song MK
    Diabetes Obes Metab; 2003 Sep; 5(5):317-24. PubMed ID: 12940869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
    Xu J; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
    Int J Biol Macromol; 2011 Nov; 49(4):657-62. PubMed ID: 21756932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medium- and long-chain fatty acid triacylglycerol reduce body fat and serum triglyceride in overweight and hypertriglyceridemic subjects].
    Zhang YH; Liu YH; Zheng ZX; Wang J; Zhang Y; Zhang RX; Yu XM; Jing HJ; Xue CY; Wu J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Sep; 43(9):765-71. PubMed ID: 20137557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
    Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects.
    Eckel RH; Hanson AS; Chen AY; Berman JN; Yost TJ; Brass EP
    Diabetes; 1992 May; 41(5):641-7. PubMed ID: 1568535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of medium-chain and long-chain triacylglycerols on the control of food intake in men.
    Van Wymelbeke V; Himaya A; Louis-Sylvestre J; Fantino M
    Am J Clin Nutr; 1998 Aug; 68(2):226-34. PubMed ID: 9701177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel chemically modified analogue of xenin-25 exhibits improved glucose-lowering and insulin-releasing properties.
    Parthsarathy V; Irwin N; Hasib A; Martin CM; McClean S; Bhat VK; Ng MT; Flatt PR; Gault VA
    Biochim Biophys Acta; 2016 Apr; 1860(4):757-64. PubMed ID: 26802310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats.
    Ríos-Lugo MJ; Cano P; Jiménez-Ortega V; Fernández-Mateos MP; Scacchi PA; Cardinali DP; Esquifino AI
    J Pineal Res; 2010 Nov; 49(4):342-8. PubMed ID: 20663045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
    Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
    Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucoregulatory effects of bombesin in lean and genetically obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Comp Biochem Physiol B; 1987; 88(1):359-62. PubMed ID: 3315420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical cholecystokinin receptor activation protects against obesity-diabetes in high fat fed mice and has sustainable beneficial effects in genetic ob/ob mice.
    Irwin N; Montgomery IA; Moffett RC; Flatt PR
    Biochem Pharmacol; 2013 Jan; 85(1):81-91. PubMed ID: 23085436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
    Liang Y; Cincotta AH
    Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medium- and long-chain triacylglycerols reduce body fat and blood triacylglycerols in hypertriacylglycerolemic, overweight but not obese, Chinese individuals.
    Zhang Y; Liu Y; Wang J; Zhang R; Jing H; Yu X; Zhang Y; Xu Q; Zhang J; Zheng Z; Nosaka N; Arai C; Kasai M; Aoyama T; Wu J; Xue C
    Lipids; 2010 Jun; 45(6):501-10. PubMed ID: 20473577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.
    Diani AR; Sawada G; Wyse B; Murray FT; Khan M
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E116-22. PubMed ID: 14532171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary sorbose prevents and improves hyperglycemia in genetically diabetic mice.
    Furuse M; Kimura C; Mabayo RT; Takahashi H; Okumura J
    J Nutr; 1993 Jan; 123(1):59-65. PubMed ID: 8421231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary (n-3) polyunsaturated fatty acids improve adipocyte insulin action and glucose metabolism in insulin-resistant rats: relation to membrane fatty acids.
    Luo J; Rizkalla SW; Boillot J; Alamowitch C; Chaib H; Bruzzo F; Desplanque N; Dalix AM; Durand G; Slama G
    J Nutr; 1996 Aug; 126(8):1951-8. PubMed ID: 8759367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Diabetes Res; 1990 Jun; 14(2):87-91. PubMed ID: 1966872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin releasing effects of adrenocorticotropin (ACTH 1-39) and ACTH fragments (1-24 and 18-39) in lean and genetically obese hyperglycaemic (ob/ob) mice.
    Bailey CJ; Flatt PR
    Int J Obes; 1987; 11(2):175-81. PubMed ID: 3038765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.